.webp)
tirzepatide 9mg Compounded (GLP-1/GIP) Dosing questions : r/BigEasyWeightLoss
Description
Journal of Drugs in Dermatology
The SURMOUNT-1 trial showed meaningful weight loss at every dose level, with 5mg producing an average 15% body weight reduction over 72 weeks
An investigation revealed that a compounding pharmacy had failed to adhere to proper sterilization procedures
Be cautious
GIP receptor activation has similar protective properties as GLP-1 receptor activation, and that improving GIP signaling in the brain may be protective in AD (Ji et al., 2016)
